Literature DB >> 19294473

SSAT controversies intramucosal esophageal cancer and high-grade dysplasia: which treatment? Surgical therapy: improved outcomes and piece of mind.

Jeffrey H Peters1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19294473     DOI： 10.1007/s11605-009-0863-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  16 in total

1.  Predictive factors of coexisting cancer in Barrett's high-grade dysplasia.

Authors:  C Tharavej; J A Hagen; J H Peters; G Portale; J Lipham; S R DeMeester; C G Bremner; T R DeMeester
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

2.  Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.

Authors:  N S Buttar; K K Wang; T J Sebo; D M Riehle; K K Krishnadath; L S Lutzke; M A Anderson; T M Petterson; L J Burgart
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

3.  Can clinical and endoscopic findings accurately predict early-stage adenocarcinoma?

Authors:  G Portale; J H Peters; C-C Hsieh; J A Hagen; S R DeMeester; T R DeMeester
Journal:  Surg Endosc       Date:  2005-12-05       Impact factor: 4.584

4.  Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome--an update.

Authors:  Elaine E Tseng; T T Wu; Charles J Yeo; Richard F Heitmiller
Journal:  J Gastrointest Surg       Date:  2003-02       Impact factor: 3.452

Review 5.  The esophageal remnant after gastric interposition.

Authors:  X B D'Journo; J Martin; P Ferraro; A Duranceau
Journal:  Dis Esophagus       Date:  2008-06-28       Impact factor: 3.429

6.  Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia.

Authors:  Christian G Peyre; Steven R DeMeester; Christian Rizzetto; Neeraj Bansal; Andrew L Tang; Shahin Ayazi; Jessica M Leers; John C Lipham; Jeffrey A Hagen; Tom R DeMeester
Journal:  Ann Surg       Date:  2007-10       Impact factor: 12.969

7.  Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma.

Authors:  Herbert C Wolfsen; Timothy A Woodward; Massimo Raimondo
Journal:  Mayo Clin Proc       Date:  2002-11       Impact factor: 7.616

8.  Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.

Authors:  Rodney J Pacifico; Kenneth K Wang; Louis-Michel Wongkeesong; Navtej S Buttar; Lori S Lutzke
Journal:  Clin Gastroenterol Hepatol       Date:  2003-07       Impact factor: 11.382

9.  Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome.

Authors:  Valerie A Williams; Thomas J Watson; Fernando A Herbella; Oliver Gellersen; Daniel Raymond; Carolyn Jones; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2007-10-02       Impact factor: 3.452

10.  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.

Authors:  D S Levine; R C Haggitt; P L Blount; P S Rabinovitch; V W Rusch; B J Reid
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.